Brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma who are Ineligible for autologous stem cell transplant: A Germany and United Kingdom retrospective study
- Resource Type
- Academic Journal
- Source
- European Journal of Haematology. Dec 01, 2017 99(6):553-558
- Subject
- Language
- English
- ISSN
- 0902-4441